Novo Nordisk Cuts, FDA Gets Tough & Clinical Research is a Real Job
Description
In this episode, Brad and Denali dive into the biggest news shaking up the clinical research world, including Novo Nordisk’s historic layoffs and what it means for the industry. We break down the FDA’s new crackdown on pharmaceutical advertising and discuss how upcoming reforms could change the way drugs are marketed to consumers. We also spotlight the ACRP’s initiative to formally recognize clinical research professionals and what that could mean for the future of the field. Plus, we take a critical look at the rise of course-selling culture in clinical research, with a special mention of the mysterious "Pharma TNT" group.
Stick around for updates on our upcoming round robin episode—if you want to join the conversation, find out how to get involved! Don’t forget to like, comment, and subscribe for more unfiltered coverage of the clinical trial industry.
United States
